Does irbesartan prevent the progression of nephropathy in patients with nephropathy due to type 2 diabetes?
Irbesartan provides renoprotection against the progression of diabetic nephropathy independent of its blood pressure-lowering effects.
The angiotensin-II-receptor blocker irbesartan is effective in protecting against the progression of nephropathy due to type 2 diabetes. This protection is independent of the reduction in blood pressure it causes.
Lewis et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: